EKF Diagnostics Holdings PLC (GB0031509804)

Overview

EKF Diagnostics Holdings plc is a global medical diagnostics company engaged in designing, developing, manufacturing, and selling a wide range of diagnostic instruments, reagents, and ancillary products. The company has a broad market reach, serving customers in Europe, the Middle East, the Americas, Asia, and Africa. Founded in 1990 and headquartered in Cardiff, United Kingdom, EKF Diagnostics stands out for its innovative solutions in the medical field, focusing on providing high-quality, reliable diagnostic tools and services to healthcare professionals and patients around the world.

Products and Services

• DiaSpect Tm and DiaSpect Hemoglobin T: Portable hand-held analyzers used for quick and reliable hemoglobin measurements.
• Hemo Control: Offers lab-quality hemoglobin results, catering to the need for accurate blood analysis.
• HemataStat II: A microhematocrit centrifuge providing quantitative hematocrit readings for six blood samples, facilitating efficient sample processing.
• Biosen C-Line GP+ and C-Line Clinic: Glucose and lactate analyzers designed for clinical and sports medicine applications, ensuring accurate and fast results.
• Quo-Lab A1c and Quo-Test A1c: Compact, desktop analyzers focused on measuring glycated hemoglobin for diabetes monitoring and management.
• STAT-Site M Beta-hydroxybutyrate: Analyzer for beta-hydroxybutyrate, aiding in the monitoring of ketosis in patients.
• Creamatocrit Plus: Analyzes lipid concentration and calorific density in mothers' milk, supporting neonatal health.
• QuPID and True20 Pregnancy Tests: Reliable, quick pregnancy tests for professional and home use.
• Lactate Scout 4: A lactate analyzer, perfect for sports and medical use, providing critical data for performance and patient care.
• Clinical Chemical Analyzers and Assays: A range of products including analyzers and markers for glycated albumin, glycated serum protein, nitro-tab ketone, and procalcitonin for diverse clinical applications from ketosis monitoring to bacterial infection and sepsis detection.
• RaPET Serology Immunoassay Kits: For immunoassay applications, ensuring reliable serological testing.
• QuStick Strep A: Facilitates the rapid detection and treatment of Strep A infection, improving patient outcomes.
• Altair 240, Excel, Micro 12: A lineup of clinical analyzers and centrifuges catering to various diagnostic needs, from blood chemistry analysis to molecular and bacteriological applications.
• Hema-Screen Serology: Analyzers for early detection of colorectal cancer, highlighting the company’s commitment to cancer diagnostics.
• Uri-Trak 120: A urine analyzer designed for accurate and efficient urinalysis, supporting comprehensive urinary tract health assessment.
• COVID-19 Kits and Services: Includes a variety of diagnostic kits and services related to COVID-19, responding to the global health emergency with timely and effective solutions.
• Contract Manufacturing and Laboratory Services: Offers contract manufacturing solutions to third-party businesses and extensive laboratory services, showcasing EKF Diagnostics’ versatility and comprehensive service offerings in the medical diagnostics field.